Inspire Medical Systems, Inc. (INSP)
Largest Insider Buys in Sector
INSP Stock Price History Chart
INSP Stock Performance
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The …
Insider Activity of Inspire Medical Systems, Inc.
Over the last 12 months, insiders at Inspire Medical Systems, Inc. have bought $0 and sold $24.15M worth of Inspire Medical Systems, Inc. stock.
On average, over the past 5 years, insiders at Inspire Medical Systems, Inc. have bought $15,350 and sold $146.86M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100 shares for transaction amount of $15,350 was made by Sparks Charisse Y (Chief Medical Officer) on 2023‑10‑12.
List of Insider Buy and Sell Transactions, Inspire Medical Systems, Inc.
| 2024-11-01 | Sale | Chief Technology Officer | 8,703 0.0296% | $193.47 | $1.68M | +1.05% | ||
| 2024-09-09 | Sale | director | 800 0.0028% | $220.00 | $176,000 | -2.28% | ||
| 2024-09-09 | Sale | Chief Technology Officer | 31 0.0001% | $215.00 | $6,665 | -2.28% | ||
| 2024-08-22 | Sale | Chief Technology Officer | 5,000 0.0171% | $189.83 | $949,143 | +9.24% | ||
| 2024-08-16 | Sale | Chief Commercial Officer | 4,861 0.0158% | $188.55 | $916,549 | 0.00% | ||
| 2024-08-15 | Sale | Chief Commercial Officer | 16,139 0.0538% | $193.10 | $3.12M | 0.00% | ||
| 2024-04-17 | Sale | Chief Financial Officer | 15,000 0.0468% | $230.03 | $3.45M | -22.67% | ||
| 2024-04-01 | Sale | CEO and President | 40,000 0.1323% | $205.09 | $8.2M | -7.63% | ||
| 2024-04-01 | Sale | director | 32 0.0001% | $213.99 | $6,848 | -7.63% | ||
| 2024-03-25 | Sale | director | 554 0.0018% | $197.81 | $109,587 | -4.87% | ||
| 2024-03-22 | Sale | Chief Technology Officer | 4,387 0.0146% | $194.40 | $852,849 | -1.06% | ||
| 2024-03-18 | Sale | director | 554 0.0018% | $193.53 | $107,216 | -1.50% | ||
| 2024-03-11 | Sale | director | 554 0.0019% | $198.05 | $109,720 | -0.81% | ||
| 2024-03-01 | Sale | director | 554 0.0018% | $179.44 | $99,410 | +6.39% | ||
| 2024-02-29 | Sale | Chief Technology Officer | 8,605 0.0289% | $179.25 | $1.54M | +9.04% | ||
| 2024-02-27 | Sale | Chief Commercial Officer | 3,060 0.0102% | $182.01 | $556,951 | +5.46% | ||
| 2024-02-23 | Sale | Chief Commercial Officer | 12,230 0.0415% | $185.37 | $2.27M | +4.94% | ||
| 2023-10-12 | Chief Medical Officer | 100 0.0004% | $153.50 | $15,350 | +26.57% | |||
| 2023-09-08 | Sale | CEO and President | 47,992 – | $0 | $0 | -17.40% | ||
| 2023-07-31 | Sale | director | 529 0.0018% | $290.47 | $153,659 | -34.31% |
Insider Historical Profitability
| Herbert Timothy P. | CEO and President | 63658 0.2135% | $210.29 | 1 | 30 | +89.73% |
| Buchholz Richard | Chief Financial Officer | 28271 0.0948% | $210.29 | 1 | 19 | +89.73% |
| McCormick Shawn | director | 23140 0.0776% | $210.29 | 1 | 1 | +89.73% |
| Ban Randy | Chief Commercial Officer | 3056 0.0102% | $210.29 | 1 | 34 | +89.73% |
| Amzak Health Investors, LLC | 10 percent owner | 1497043 5.02% | $210.29 | 1 | 0 | +89.73% |
Institutional Investor Ownership
| Fidelity Investments | $953.19M | 14.94 | 4.44M | +36.23% | +$253.5M | 0.06 | |
| The Vanguard Group | $621.26M | 9.74 | 2.89M | -1.33% | -$8.39M | 0.01 | |
| Wellington Management Company | $419.41M | 6.57 | 1.95M | +36.52% | +$112.2M | 0.07 | |
| BlackRock | $406.17M | 6.37 | 1.89M | +5.04% | +$19.51M | 0.01 | |
| Baillie Gifford Co | $315.23M | 4.94 | 1.47M | +19.33% | +$51.06M | 0.25 |